Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 1007 | 2022 |
Homologous and heterologous Covid-19 booster vaccinations RL Atmar, KE Lyke, ME Deming, LA Jackson, AR Branche, HM El Sahly, ... New England Journal of Medicine 386 (11), 1046-1057, 2022 | 521 | 2022 |
VivaGel™ (SPL7013 Gel): A candidate dendrimer – microbicide for the prevention of HIV and HSV infection R Rupp, SL Rosenthal, LR Stanberry International journal of nanomedicine 2 (4), 561-566, 2007 | 377 | 2007 |
Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2. 4xM2e) in healthy adults CB Turley, RE Rupp, C Johnson, DN Taylor, J Wolfson, L Tussey, ... Vaccine 29 (32), 5145-5152, 2011 | 325 | 2011 |
Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes SL Rosenthal, R Rupp, GD Zimet, HM Meza, ML Loza, MB Short, ... Journal of Adolescent Health 43 (3), 239-245, 2008 | 262 | 2008 |
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial DI Bernstein, FM Munoz, ST Callahan, R Rupp, SH Wootton, KM Edwards, ... Vaccine 34 (3), 313-319, 2016 | 226 | 2016 |
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant KE Lyke, RL Atmar, CD Islas, CM Posavad, D Szydlo, RP Chourdhury, ... Cell Reports Medicine 3 (7), 2022 | 149 | 2022 |
Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial MJ Mulligan, DI Bernstein, P Winokur, R Rupp, E Anderson, N Rouphael, ... Jama 312 (14), 1409-1419, 2014 | 142 | 2014 |
Heterologous SARS-CoV-2 booster vaccinations–preliminary report RL Atmar, KE Lyke, ME Deming, LA Jackson, AR Branche, HM El Sahly, ... MedRxiv, 2021 | 95 | 2021 |
Six-month safety data of recombinant vesicular stomatitis virus–Zaire Ebola virus envelope glycoprotein vaccine in a phase 3 double-blind, placebo-controlled randomized study … SA Halperin, JR Arribas, R Rupp, CP Andrews, L Chu, R Das, JK Simon, ... The Journal of infectious diseases 215 (12), 1789-1798, 2017 | 89 | 2017 |
Ethnic and gender disparities in needed adolescent mental health care F John, JR Temple, N Perez, R Rupp Journal of Health Care for the Poor and Underserved 22 (1), 101-110, 2011 | 88 | 2011 |
Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: a phase 1b randomized study R Rupp, GJ Luckasen, JL Kirstein, JE Osorio, JD Santangelo, M Raanan, ... Vaccine 33 (46), 6351-6359, 2015 | 83 | 2015 |
Factors associated with completion of the human papillomavirus vaccine series TPL Neubrand, C Radecki Breitkopf, R Rupp, D Breitkopf, SL Rosenthal Clinical pediatrics 48 (9), 966-969, 2009 | 81 | 2009 |
Maternal and infant outcomes among women vaccinated against pertussis during pregnancy AB Berenson, JM Hirth, M Rahman, TH Laz, RE Rupp, KO Sarpong Human vaccines & immunotherapeutics 12 (8), 1965-1971, 2016 | 77 | 2016 |
A brief educational intervention increases providers' human papillomavirus vaccine knowledge AB Berenson, M Rahman, JM Hirth, RE Rupp, KO Sarpong Human vaccines & immunotherapeutics 11 (6), 1331-1336, 2015 | 67 | 2015 |
Phase 1 clinical trial of a conditionally replication-defective human cytomegalovirus (CMV) vaccine in CMV-seronegative subjects SP Adler, N Lewis, A Conlon, MP Christiansen, M Al-Ibrahim, R Rupp, ... The Journal of infectious diseases 220 (3), 411-419, 2019 | 62 | 2019 |
A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants R Rupp, D Hurley, S Grayson, J Li, K Nolan, RD McFetridge, J Hartzel, ... Human vaccines & immunotherapeutics 15 (3), 549-559, 2019 | 52 | 2019 |
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults≥ 50 years of age SJ Ermlich, CP Andrews, S Folkerth, R Rupp, D Greenberg, ... Vaccine 36 (45), 6875-6882, 2018 | 49 | 2018 |
Parental influences on adolescent sexual behaviors. R Rupp, SL Rosenthal Adolescent medicine: state of the art reviews 18 (3), 460-70, vi, 2007 | 46 | 2007 |
A replication-defective human cytomegalovirus vaccine elicits humoral immune responses analogous to those with natural infection Y Liu, DC Freed, L Li, A Tang, F Li, EM Murray, SP Adler, MA McVoy, ... Journal of virology 93 (23), 10.1128/jvi. 00747-19, 2019 | 44 | 2019 |